<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab4">
 <label>Table 4.4</label>
 <caption>
  <p>Uses of seroepidemiology in immunization programs</p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td>1. Cross-sectional surveys to determine the need for immunization programs in:</td>
   </tr>
   <tr>
    <td> (a) Different age groups</td>
   </tr>
   <tr>
    <td>  6–20 months—measure duration of maternal antibody</td>
   </tr>
   <tr>
    <td>  School/college entry—identify omissions, failures, loss of protective antibody</td>
   </tr>
   <tr>
    <td> (b) Different geographic areas</td>
   </tr>
   <tr>
    <td> (c) Different socioeconomic groups</td>
   </tr>
   <tr>
    <td> (d) High-risk occupational groups</td>
   </tr>
   <tr>
    <td>2. Follow-up measurements in immunized persons to determine:</td>
   </tr>
   <tr>
    <td> (a) Proportion developing local, humoral, cell-mediated immune responses</td>
   </tr>
   <tr>
    <td> (b) Quality and extent of response</td>
   </tr>
   <tr>
    <td> (c) Nature and degree of interaction between vaccine components</td>
   </tr>
   <tr>
    <td> (d) Duration of response</td>
   </tr>
   <tr>
    <td> (e) Level of protection against disease and asymptomatic infection</td>
   </tr>
   <tr>
    <td> (f) Degree of spread of live vaccine strains to exposed and susceptible contacts</td>
   </tr>
   <tr>
    <td>3. Periodic serological surveillance to identify groups who are not receiving vaccines or who have inadequate responses</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
